Global Serological Testing Market Size study, by Technology (ELISA, NAT, CLIA/CMIA and Others), Product (Instruments and Consumables & Reagents), Application (Hepatitis, Coronavirus (COVID-19), Human Immunodeficiency Virus (HIV), Rotavirus Infections, And

Global Serological Testing Market Size study, by Technology (ELISA, NAT, CLIA/CMIA and Others), Product (Instruments and Consumables & Reagents), Application (Hepatitis, Coronavirus (COVID-19), Human Immunodeficiency Virus (HIV), Rotavirus Infections, And Others), End-User (Diagnostic Laboratories, Hospitals and Other End Users), and Regional Forecasts 2022-2028

Global Serological Testing Market is valued at approximately USD XXX million in 2021 and is anticipated to grow with a healthy growth rate of more than 8.8% over the forecast period 2022-2028. A serological test is a type of medical examination that tests for the presence of antiviral antibodies in blood samples. A person who has been exposed to the virus should have a high level of antiviral antibodies in their blood. Demand for serology testing has increased to count COVID-19 cases more accurately, including individuals who are expected to recover or are not showing symptoms. The market growth is driven by the key factors such as implementation of Favorable Government Initiatives & External Funding for R&D and growing Burden of Chronic Diseases. For instance, around 1.5 million new cases of the hepatitis C virus are reported each year, with an estimated 58 million individuals worldwide carrying the illness. Additionally, according to estimates from the World Health Organization, 290000 persons died from hepatitis C in 2019, primarily due to cirrhosis and hepatocellular carcinoma (primary liver cancer). As a result, throughout the duration of the forecast period, the rising number of hepatitis cases would probably lead to an increase in demand for these diagnostic tests, pushing the market. On the other side, according to report from the World Health Organization (WHO), the rate of serological tests has risen for the year 2020 compared to 2019. As a result, the need for consumables and reagents for the testing procedure is rising due to the expansion of serological testing, which is fueling market expansion. However, high cost of serological tests impedes the growth of the market over the forecast period of 2022-2028.

The key regions considered for the global Serological Testing Market study include Asia Pacific, North America, Europe, Latin America, and Rest of the World. Europe is leading the global market shares owing to increasing healthcare expenditure and growing healthcare awareness. On the other side, Asia Pacific is expected to be the fastest growing region in upcoming years. This is due to the growth of infectious illnesses in emerging nations like China and India, rising public awareness of health issues, and an increase in the region's disposable income.

Major market players included in this report are:
Advanced Diagnostics, Inc.
Randox Laboratories Ltd.
Cellex Inc.
F. Hoffmann La-Roche Ltd
Eurofins Scientific
Quest Diagnostics
Thermo Fisher Scientific, Inc.
ELITechGroup
Abbott
Becton, Dickinson and Company (BD)

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and Application offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Technology:
ELISA
NAT
CLIA/CMIA
Others
By Product:
Instruments
Consumables and Reagents
By Application:
Hepatitis
Coronavirus (COVID-19)
Human Immunodeficiency Virus (HIV)
Rotavirus infections
Others
By End User:
Diagnostic Laboratories
Hospitals
Other End Users
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2018, 2019, 2020
Base year – 2021
Forecast period – 2022 to 2028

Target Audience of the Global Serological Testing Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors

Companies Mentioned

Advanced Diagnostics, Inc.
Randox Laboratories Ltd.
Cellex Inc.
F. Hoffmann La-Roche Ltd
Eurofins Scientific
Quest Diagnostics
Thermo Fisher Scientific, Inc.
ELITechGroup
Abbott
Becton, Dickinson and Company (BD)

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.